Based on the observation that the dissolving-microneedle-patch loaded and delivered the OVA antigens and induced greater immunization as an adjuvant to stimulate OVA-specific CD8+ T cell activation, we further investigated whether this response could protect the mice from a graft of OVA-expressing EG7 tumor cells. This evidence concerns the gene CD8A and neoplasm.